Zenotech Laboratories Limited (BOM:532039)

Market Cap	2.84B
Revenue (ttm)	403.29M
Net Income (ttm)	31.29M
Shares Out	61.03M
EPS (ttm)	0.56
PE Ratio	82.96
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,350
Average Volume	8,615
Open	45.71
Previous Close	45.71
Day's Range	44.10 - 46.48
52-Week Range	43.85 - 72.87
Beta	-0.17
RSI	48.88
Earnings Date	Jan 23, 2026

About Zenotech Laboratories

Zenotech Laboratories Limited manufactures and markets pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India. It offers contract manufacturing services for parenteral depot formulations, ophthalmic, oncology oral and injectables, and general injectables. The company also leases out its biotech facility and equipment. In addition, it provides granulocyte-colony stimulating factor and granulocyte-macrophage colony-stimulating factor products. Zenotech Laboratories Limited was incorporated in 1989 and is ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1989
• Employees: 228
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532039

Financial Performance

In 2024, Zenotech Laboratories's revenue was 390.98 million, an increase of 6.22% compared to the previous year's 368.09 million. Earnings were 56.13 million, a decrease of -32.36%.